Pardes Biosciences
IPO- Employees
- 1–10
- Website
- pardesbio.com
- Type
- Public
About
Similar Companies
Sana BiotechnologyIPO
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Seattle, United States201–500Biotech, Healthcare
Series D·$1.4B·Jun 2020

Abogen Biosciences
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Suzhou, China201–500Biotech, mRNA Therapeutics
Extension Round·$1.3B·Nov 2021
Alnylam PharmaceuticalsIPO
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Cambridge, United States1001–5000Biotech, Genomics
Corporate Round·$1.0B·Apr 2020
ArsenalBio
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
San Francisco, United States201–500Biotech, Life Sciences
Series C·$955.0M·Sep 2024
Lyell ImmunopharmaIPO
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
South San Francisco, United States201–500Biotech, Healthcare
Venture Round·$884.0M·Jul 2025
Pharmaceutical Product Development, Inc. (PPD)Acquired
Global contract research organization providing comprehensive drug development and laboratory ser...
Wilmington, United States10001+Biotech, Healthcare
Private Equity·$3.9B·Jan 2019